Oncology News

Liz D'Amato has a story that is all too common. In November of last year, the mother of three from Dayton received a phone call that confirmed a diagnosis thousands of women receive each year: cancer.

"Your body cannot heal without play. Your mind cannot heal without laughter. Your soul cannot heal without joy."

Sydney, 4, and Easton Ulseth, 2, take a turn on Santa's lap Friday night during the Celebration of Lights at Northside Hospital-Forsyth.

As Ryan Eaton lay in hospital beds, receiving treatment for synovial sarcoma that would eventually metastasize and spread throughout his body, he worried about other people.

Millennium: The Takeda Oncology Company with its parent company, Takeda Pharmaceutical Company Limited , today announced results from a retrospective, subgroup analysis of the Phase 3 VISTA study that showed a higher cumulative dose of VELCADE suggests improved overall survival in previously untreated patients with multiple myeloma .

In this October 2012 photo provided by The Children's Hospital of Philadelphia, Emily Whitehead is checked by pediatric oncologist, Dr. Stephan A. Grupp, at the hospital.

Due to promising preliminary results, officials at the National Cancer Institute decided to release them early on December 5 before a full analysis of the trial was completed Due to promising preliminary results, officials at the National Cancer Institute decided to release them early on December 5 before a full analysis of the trial was completed ... (more)

ZIOPHARM Oncology, Inc. today announced the unanimous approval of the National Institutes of Health's Recombinant DNA Advisory Committee for the initiation of a Phase 1 study of Ad-RTS-IL-12, an adenoviral vector engineered to express interleukin-12 under the control of veledimex, an oral activator, in subjects with recurrent or progressive ... (more)

Fowler High student Gabriel Rodriguez holds a present and Christmas poster he drew, as he and other members of the school's Redcat Men's Alliance wait to give the presents to young patients at Children's Hospital Central California, Friday afternoon, December 6, 2013.

One of hardest parts of a doctor's job - delivering bad news to patients and their loved ones - is rarely addressed in medical school.

The most-recognized oncology and hematology brand in North America is Epogen . The brand was most recognized by 4.9 percent of physicians in a survey conducted by Brand Institute Inc. during second-quarter 2013.

The drug candidate used in the research has been developed by scientists from Karolinska Institutet and a Swedish company following its initial identification at the same university.

Today Biocartis and VIB announced their exclusive license agreement on a novel panel of microsatellite instability biomarkers for several cancers, in particular colorectal cancer .

The members of William House, who chose the Teenage Cancer Trust to be their charity following the death of fellow pupil Georgie Brock in 2009, raised the cash in just three years.

Hematologist and Oncologist Swati Sehgal has joined White Plains Hospital Physician Associates Oncology & Hematology, a division of the hospital aligning physicians with Hospital services.

Minister for Health James Reilly has said the salary and conditions of Director General of the HSE Tony O' Brien are perfectly in line with public pay policy.

IU Goshen Center for Cancer Care is using an advanced treatment called HIPEC which stands for Hyperthermic Intraperitoneal Chemotherapy.

Xiaowei Wang, PhD, and his colleagues have designed synthetic molecules that combine the advantages of two experimental RNA therapies against cancer.

The Triangle's two major cancer centers didn't make the list, but GlaxoSmithKline has lined up six other major global research institutions to collaborate on research into new ways to fight cancer using a mix of drugs.

Angiochem, a clinical stage biotechnology company developing drugs that are uniquely capable of crossing the blood-brain barrier , today announced that its lead oncology compound, ANG1005, a novel paclitaxel-peptide drug conjugate in development for breast cancer patients with brain metastasis and patients with primary brain cancer, and ANG4043, a ... (more)